Paula Soteropoulos
CIK 1692444 · Chief Executive Officer · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$557.0K
Companies
4
Total Filings
39
Lifetime Open-Market Net
-$5.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNTH | Director | 0 | $82.07 | $0 | -$2.25M | 7 | 2026-05-22 |
| RLYB | Director | — | $15.92 | — | $0 | 5 | 2025-05-15 |
| QURE | Director | 20,203 | $27.57 | $557.0K | -$1.92M | 22 | 2024-06-17 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Chief Executive Officer | 1,711,079 | — | — | -$1.61M | 5 | 2019-09-30 |
Recent Filings · Page 4 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-04-09 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Mixed | — | -$814.8K | EDGAR |
| 2019-03-07 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Mixed | — | -$471.7K | EDGAR |
| 2019-01-30 | QURE | Sell (S) | −1,210 | -$37.9K | EDGAR |
| 2019-01-29 | QURE | Grant (A) | +3,230 | $0 | EDGAR |
| 2019-01-04 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-31 | QURE | Sell (S) | −2,878 | -$53.3K | EDGAR |
| 2018-01-30 | QURE | Grant (A) | +4,792 | $0 | EDGAR |
| 2018-01-04 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-31 | QURE | Grant (A) | — | $0 | EDGAR |
Showing 31–39 of 39
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.